Clinical Social Workers in Ft Sam Houstin, TX Accepting Medicare
1 Clinical Social Workers found. Showing 1 - 1
 Georgeanne Greene, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Bamc Dept Of Social Work, 3851 Roger Brooke Drive, Ft Sam Houstin, TX 78234 Phone: 210-916-3020 Fax: 210-916-1073 |
News Archive
Personalized vaccine processed using tumor tissue promising for brain tumor treatment
Each day in the United States, 482 people are diagnosed with a brain tumor. For these 482 people, not many treatments exist. With the current treatments available, only 5% of those diagnosed with a Glioblastoma Multiform will survive more than 5 years. Only two new treatments have been approved by the FDA in the past two decades.
Mutation that causes sickle cell anemia may offer new way to treat drug-resistant cancers
The genetic mutation that causes sickle cell anemia also turns red blood cells into potent tumor killers and may offer a new way to treat cancers that are resistant to existing treatments, according to research published January 9, 2013 in the open access journal PLOS ONE by David S. Terman of Jenomic Research Institute and colleagues from Duke University and other institutions.
Shionogi's CUVPOSA receives FDA approval for treatment of chronic severe drooling
Shionogi Inc., a U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. Food and Drug Administration approval of CUVPOSA™ (glycopyrrolate), the first liquid treatment for patients ages 3-16 who suffer from chronic severe drooling associated with neurologic conditions such as cerebral palsy. CUVPOSA™ was designated an Orphan Drug by the FDA.
USPTO grants Cenestra Health patent relating to high-purity omega-3 fatty acid formulations
Cenestra Health announced today that the U.S. Patent and Trademark Office has issued a key patent related to the company's high-purity omega-3 fatty acid formulations and their methods of use. U.S. Patent No. 7652068, entitled "Omega-3 Fatty Acid Formulations," covers a unique, high-purity formulation of the omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid).
Review launched into impact of potential bias in the design and use of medical devices
A far-reaching review is being launched into the impact of potential bias in the design and use of medical devices.
› Verified 7 days ago